Cargando…

The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma

BACKGROUND: Esophageal squamous cell carcinoma was treated by operation and chemoradiotherapy. However, the prognosis of most patients is poor after treatment, and most studies have shown that FGF2 and its receptor (FGFR) are involved in the development of various malignant tumors. FGF2 plays an imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wenjing, Zhou, Yaxing, Li, Chao, Xu, Shanshan, Li, Mengyan, Liu, Wenying, Ma, Yuqing, Wang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748917/ https://www.ncbi.nlm.nih.gov/pubmed/33381388 http://dx.doi.org/10.1155/2020/2872479

Ejemplares similares

Prognostic value of MTA1, SOX4 and EZH2 expression in esophageal squamous cell carcinoma
por: Liu, Wenying, et al.
Publicado: (2021)

Expression of Twist, Slug and Snail in esophageal squamous cell carcinoma and their prognostic significance
por: Xu, Shanshan, et al.
Publicado: (2021)

Prognostic Value of GPNMB, EGFR, p-PI3K, and Ki-67 in Patients with Esophageal Squamous Cell Carcinoma
por: Wang, Bo, et al.
Publicado: (2022)

Prognostic value of SOX2, Cyclin D1, P53, and ki-67 in patients with esophageal squamous cell carcinoma
por: Wang, Hui, et al.
Publicado: (2018)

Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma
por: Kwon, Dohee, et al.
Publicado: (2016)

The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma
por: Saito, Shin, et al.
Publicado: (2015)

Addiction of mesenchymal phenotypes on the FGF/FGFR axis in oral squamous cell carcinoma cells
por: Osada, Asami Hotta, et al.
Publicado: (2019)

Expression and function analysis of CRABP2 and FABP5, and their ratio in esophageal squamous cell carcinoma
por: Li, Mengyan, et al.
Publicado: (2021)

Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
por: Yang, Chaofeng, et al.
Publicado: (2012)

miR-4432 Targets FGFBP1 in Human Endothelial Cells
por: Avvisato, Roberta, et al.
Publicado: (2023)

FGF19–FGFR4 Signaling in Hepatocellular Carcinoma
por: Raja, Aroosha, et al.
Publicado: (2019)

The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy
por: Shim, Hyun-Jeong, et al.
Publicado: (2016)

POLD2 and KSP37 (FGFBP2) Correlate Strongly with Histology, Stage and Outcome in Ovarian Carcinomas
por: Elgaaen, Bente Vilming, et al.
Publicado: (2010)

FGF/FGFR signaling in health and disease
por: Xie, Yangli, et al.
Publicado: (2020)

The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2015)

Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2‐FGFR1 autocrine loop
por: Cen, Mengyuan, et al.
Publicado: (2018)

Prognostic significance of platelet-to-albumin ratio in patients with esophageal squamous cell carcinoma receiving definitive radiotherapy
por: Huang, Zhiyu, et al.
Publicado: (2022)

Correction: POLD2 and KSP37 (FGFBP2) Correlate Strongly with Histology, Stage and Outcome in Ovarian Carcinomas
por: Elgaaen, Bente Vilming, et al.
Publicado: (2010)

Patterns and prognostic predictive value of perineural invasion in esophageal squamous cell carcinoma
por: Ma, Yu, et al.
Publicado: (2022)

FGFBP1 as a potential biomarker predicting bacillus Calmette–Guérin response in bladder cancer
por: Li, Fei, et al.
Publicado: (2022)

Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
por: Li, Yan, et al.
Publicado: (2022)

Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas
por: Jomrich, Gerd, et al.
Publicado: (2019)

Expression and Prognostic Value of Id-4 in Patients with Esophageal Squamous Cell Carcinoma
por: Wang, Xinyu, et al.
Publicado: (2020)

FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma
por: von Loga, Katharina, et al.
Publicado: (2015)

Increases prognostic value of clinical-pathological nomogram in patients with esophageal squamous cell carcinoma
por: Hu, Jing Feng, et al.
Publicado: (2023)

Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
por: Agrawal, Archita, et al.
Publicado: (2018)

Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
por: KATO, HIROAKI, et al.
Publicado: (2013)

Blocking FGFR4 exerts distinct anti‐tumorigenic effects in esophageal squamous cell carcinoma
por: Xin, Zhongwei, et al.
Publicado: (2018)

Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism
por: Tassi, Elena, et al.
Publicado: (2018)

Clinical significance and prognostic value of TRIM24 expression in esophageal squamous cell carcinoma
por: Chi, Jun, et al.
Publicado: (2016)

Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma
por: Qin, Hui, et al.
Publicado: (2019)

Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
por: Ruan, Ruiwen, et al.
Publicado: (2023)

Melatonin Suppresses Oral Squamous Cell Carcinomas Migration and Invasion through Blocking FGF19/FGFR 4 Signaling Pathway
por: Wang, Leilei, et al.
Publicado: (2021)

Expression of a Secreted Fibroblast Growth Factor Binding Protein-1 (FGFBP1) in Angioproliferative Kaposi Sarcoma
por: Ray, Patricio E, et al.
Publicado: (2014)

FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
por: Gao, Lixia, et al.
Publicado: (2017)

FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention
por: Wang, Yijun, et al.
Publicado: (2021)

Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma
por: zhang, Lan, et al.
Publicado: (2020)

RBBP7 is a prognostic biomarker in patients with esophageal squamous cell carcinoma
por: Yu, Ning, et al.
Publicado: (2018)

The Prognostic Value of Peripheral Benzodiazepine Receptor in Patients with Esophageal Squamous Cell Carcinoma
por: Chen, You-Fang, et al.
Publicado: (2017)

The prognostic value of B7-H6 in esophageal squamous cell carcinoma
por: Zhou, Huan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8t05ktnka9og3al7autp1vnvfc